Enveric Biosciences (ENVB) Institutional Ownership $0.91 -0.10 (-9.90%) Closing price 04:00 PM EasternExtended Trading$0.93 +0.02 (+1.76%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Enveric Biosciences (NASDAQ:ENVB)CurrentInstitutional OwnershipPercentage13.82%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.27MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$41.90K Get ENVB Insider Trade Alerts Want to know when executives and insiders are buying or selling Enveric Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ENVB Institutional Buying and Selling by Quarter Enveric Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2025 AdvisorShares Investments LLC103,679$125K0.0%+14.8%4.198% 5/12/2025 Virtu Financial LLC25,622$36K0.0%-54.1%1.036% 2/14/2025 AdvisorShares Investments LLC599,854$215K0.0%+63.4%88.214% 8/8/2024 AdvisorShares Investments LLC317,047$190K0.0%+32.7%3.988% 5/20/2024 Virtu Financial LLC33,835$34K0.0%N/A0.437% 2/13/2024 Armistice Capital LLC273,000$355K0.0%N/A9.964% 11/6/2023 AdvisorShares Investments LLC146,833$339K0.1%+46.2%6.729% 8/9/2023 AdvisorShares Investments LLC100,429$338K0.1%-29.8%4.828% 5/9/2023 AdvisorShares Investments LLC143,016$240K0.1%+23.0%6.876% 8/12/2022 Ikarian Capital LLC223,834$48K0.0%-47.2%21.237% Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022 AdvisorShares Investments LLC1,252,390$268K0.1%+35.8%118.823% 5/10/2022 Mirae Asset Global Investments Co. Ltd.286,267$94K0.0%-27.1%0.544% 5/9/2022 AdvisorShares Investments LLC922,371$304K0.1%+206.9%1.754% 2/8/2022 Mirae Asset Global Investments Co. Ltd.392,920$365K0.0%N/A1.252% 1/31/2022 AdvisorShares Investments LLC300,524$279K0.0%+740.5%0.958% 11/16/2021 Squarepoint Ops LLC13,273$27K0.0%N/A0.062% 11/12/2021 Renaissance Technologies LLC492,553$1.02M0.0%N/A2.298% 11/12/2021Vident Investment Advisory LLC25,152$52K0.0%N/A0.117% 11/12/2021 Scotia Capital Inc.94,395$195K0.0%N/A0.440% 11/9/2021BlackRock Inc.500,078$1.04M0.0%-1.8%2.334% 11/4/2021 AdvisorShares Investments LLC35,754$74K0.0%N/A0.167% 9/17/2021 Virtu Financial LLC52,943$126K0.0%-70.8%0.247% 8/16/2021 State Street Corp88,886$212K0.0%N/A0.416% 8/13/2021 Northern Trust Corp36,504$87K0.0%+228.5%0.171% 8/13/2021 Geode Capital Management LLC98,894$235K0.0%+56.7%0.462% 8/12/2021 Penserra Capital Management LLC26,986$52K0.0%N/A0.126% 8/4/2021 Creative Planning17,577$42K0.0%N/A0.082% (Data available from 1/1/2016 forward) ENVB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENVB shares? During the previous two years, the following institutional investors and hedge funds held shares of Enveric Biosciences shares: Armistice Capital LLC ($355K), and AdvisorShares Investments LLC ($125K), Virtu Financial LLC ($36K).Learn more on Enveric Biosciences' institutional investors. What percentage of Enveric Biosciences' stock is owned by institutional investors? 13.82% of Enveric Biosciences' stock is owned by institutional investors. Learn more on ENVB's institutional investor holdings. Which institutional investors have been buying Enveric Biosciences' stock? The following institutional investors have purchased Enveric Biosciences' stock in the last 24 months: AdvisorShares Investments LLC ($370.78K), Armistice Capital LLC ($273K), and Virtu Financial LLC ($33.84K). How much institutional buying is happening at Enveric Biosciences? Institutional investors have bought a total of 246,162 shares in the last 24 months. This purchase volume represents approximately $1.27M in transactions. Which of Enveric Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Enveric Biosciences stock in the last 24 months: Virtu Financial LLC ($30.14K). How much institutional selling is happening at Enveric Biosciences? Institutional investors have sold a total of 30,141 shares in the last 24 months. This volume of shares sold represents approximately $41.90K in transactions. Related Companies SYBX Major Shareholders EDSA Major Shareholders LPCN Major Shareholders CMMB Major Shareholders MRKR Major Shareholders ATHA Major Shareholders NRSN Major Shareholders BLRX Major Shareholders IMNN Major Shareholders MTEX Major Shareholders This page (NASDAQ:ENVB) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.